The DOI matches its Crossref record.
Synthesis and Selective Cytotoxicity of a Hyaluronic Acid−Antitumor Bioconjugate
Abstract
A cell-targeted prodrug was developed for the anti-cancer drug Taxol, using hyaluronic acid (HA) as the drug carrier. HA-Taxol bioconjugates were synthesized by linking the Taxol 2'-OH via a succinate ester to adipic dihydrazide-modified HA (HA-ADH). The coupling of Taxol-NHS ester and HA-ADH provided several HA bioconjugates with different levels of ADH modification and different Taxol loadings. A fluorescent BODIPY-HA was also synthesized to illustrate cell targeting and uptake of chemically modified HA using confocal microscopy. HA-Taxol conjugates showed selective toxicity toward the human cancer cell lines (breast, colon, and ovarian) that are known to overexpress HA receptors, while no toxicity was observed toward a mouse fibroblast cell line at the same concentrations used with the cancer cells. The drug carrier HA-ADH was completely nontoxic. The selective cytotoxicity is consistent with the results from confocal microscopy, which demonstrated that BODIPY-HA only entered the cancer cell lines.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
BODIPY Dyes and Their Derivatives: Syntheses and Spectroscopic Properties
Loudet, A., & Burgess, K. (2007) · Chemical Reviews · doi:10.1021/cr078381n · Cited by 5,238
Regulation of lung injury and repair by Toll-like receptors and hyaluronan
Jiang, D., Liang, J., Fan, J., Yu, S., Chen, S., Luo, Y., Prestwich, G. D., Mascarenhas, M. M., Garg, H. G., Quinn, D. A., et al. (2005) · Nature Medicine · doi:10.1038/nm1315 · Cited by 1,401
Self-citationThe biology and role of CD44 in cancer progression: Therapeutic implications
Chen, C., Zhao, S., Karnad, A., & Freeman, J. W. (2018) · Journal of Hematology & Oncology · doi:10.1186/s13045-018-0605-5 · Cited by 1,245
Molecular basis for the explanation of the exponential growth of polyelectrolyte multilayers
Picart, C., Mutterer, J., Richert, L., Luo, Y., Prestwich, G. D., Schaaf, P., Voegel, J.-C., & Lavalle, P. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.202486099 · Cited by 904
Self-citationMisra, S., Hascall, V. C., Markwald, R. R., & Ghatak, S. (2015) · Frontiers in Immunology · doi:10.3389/fimmu.2015.00201 · Cited by 830
Schanté, C. E., Zuber, G., Herlin, C., & Vandamme, T. F. (2011) · Carbohydrate Polymers · doi:10.1016/j.carbpol.2011.03.019 · Cited by 708
High and low molecular weight hyaluronic acid differentially influence macrophage activation
Rayahin, J. E., Buhrman, J. S., Zhang, Y., Koh, T. J., & Gemeinhart, R. A. (2015) · ACS Biomaterials Science & Engineering · doi:10.1021/acsbiomaterials.5b00181 · Cited by 605
Hyaluronic acid targeting of CD44 for cancer therapy: from receptor biology to nanomedicine
Mattheolabakis, G., Milane, L., Singh, A., & Amiji, M. M. (2015) · Journal of Drug Targeting · doi:10.3109/1061186x.2015.1052072 · Cited by 597
Self-assembled hyaluronic acid nanoparticles for active tumor targeting
Choi, K. Y., Chung, H., Min, K. H., Yoon, H. Y., Kim, K., Park, J. H., Kwon, I. C., & Jeong, S. Y. (2010) · Biomaterials · doi:10.1016/j.biomaterials.2009.09.030 · Cited by 578
Mechanisms of drug release in nanotherapeutic delivery systems
Wong, P. T., & Choi, S. K. (2015) · Chemical Reviews · doi:10.1021/cr5004634 · Cited by 507
Hyaluronan–CD44 interactions as potential targets for cancer therapy
Misra, S., Heldin, P., Hascall, V. C., Karamanos, N. K., Skandalis, S. S., Markwald, R. R., & Ghatak, S. (2011) · The FEBS Journal · doi:10.1111/j.1742-4658.2011.08071.x · Cited by 494
Li, J., Huo, M., Wang, J., Zhou, J., Mohammad, J. M., Zhang, Y., Zhu, Q., Waddad, A. Y., & Zhang, Q. (2012) · Biomaterials · doi:10.1016/j.biomaterials.2011.11.022 · Cited by 468
Cai, S., Liu, Y., Zheng Shu, X., & Prestwich, G. D. (2005) · Biomaterials · doi:10.1016/j.biomaterials.2005.03.012 · Cited by 422
Self-citationHyaluronic acid: a unique topical vehicle for the localized delivery of drugs to the skin
Brown, M., & Jones, S. (2005) · Journal of the European Academy of Dermatology and Venereology · doi:10.1111/j.1468-3083.2004.01180.x · Cited by 373
Target-specific intracellular delivery of siRNA using degradable hyaluronic acid nanogels
Lee, H., Mok, H., Lee, S., Oh, Y.-K., & Park, T. G. (2007) · Journal of Controlled Release · doi:10.1016/j.jconrel.2007.02.011 · Cited by 365
Hyaluronan: Pharmaceutical Characterization and Drug Delivery
Liao, Y.-H., Jones, S. A., Forbes, B., Martin, G. P., & Brown, M. B. (2005) · Drug Delivery · doi:10.1080/10717540590952555 · Cited by 342
Glycosaminoglycan hydrogel films as bio-interactive dressings for wound healing
Kirker, K. R., Luo, Y., Nielson, J. H., Shelby, J., & Prestwich, G. D. (2002) · Biomaterials · doi:10.1016/s0142-9612(02)00100-x · Cited by 340
Self-citationLee, Y., Lee, H., Kim, Y. B., Kim, J., Hyeon, T., Park, H., Messersmith, P. B., & Park, T. G. (2008) · Advanced Materials · doi:10.1002/adma.200800756 · Cited by 321
Choi, K. Y., Min, K. H., Na, J. H., Choi, K., Kim, K., Park, J. H., Kwon, I. C., & Jeong, S. Y. (2009) · Journal of Materials Chemistry · doi:10.1039/b900456d · Cited by 272
Lv, Y., Xu, C., Zhao, X., Lin, C., Yang, X., Xin, X., Zhang, L., Qin, C., Han, X., Yang, L., et al. (2018) · ACS Nano · doi:10.1021/acsnano.7b08051 · Cited by 235
Hyaluronan-conjugated liposomes encapsulating gemcitabine for breast cancer stem cells
Han, Shin, D. H., Kim, J. S., Weon, K. Y., Jang, C.-Y., & Kim, J.-S. (2016) · International Journal of Nanomedicine · doi:10.2147/ijn.s95850 · Cited by 65
Trends in biopolymer science applied to cosmetics
Mendoza‐Muñoz, N., Leyva‐Gómez, G., Piñón‐Segundo, E., Zambrano‐Zaragoza, M. L., Quintanar‐Guerrero, D., Del Prado Audelo, M. L., & Urbán‐Morlán, Z. (2023) · International Journal of Cosmetic Science · doi:10.1111/ics.12880 · Cited by 42
Metadata
- Authors
- Luo, Y., & Prestwich, G. D.
- Venue
- Bioconjugate Chemistry
- Publisher
- American Chemical Society (ACS)
- Published
- 1999-07-27
- Volume
- 10
- Issue
- 5
- Pages
- 755-763
- ISSN
- 1043-1802 (ISSN-L)
- 1520-4812
- OpenAlex
- W2019188119
- Cited by
- 305
- References
- 0
- FWCI
- 3.44
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.